Predictive Oncology Inc (POAI)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
Jul 03, 16:00
Predictive Oncology Free Cash Flow: -13.44M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -13.44M |
December 31, 2023 | -13.49M |
September 30, 2023 | -13.72M |
June 30, 2023 | -13.46M |
March 31, 2023 | -13.15M |
December 31, 2022 | -12.85M |
September 30, 2022 | -13.49M |
June 30, 2022 | -13.71M |
March 31, 2022 | -12.63M |
December 31, 2021 | -13.17M |
September 30, 2021 | -11.73M |
June 30, 2021 | -12.01M |
March 31, 2021 | -13.33M |
December 31, 2020 | -12.62M |
September 30, 2020 | -12.92M |
June 30, 2020 | -11.47M |
March 31, 2020 | -9.713M |
December 31, 2019 | -8.759M |
September 30, 2019 | -7.189M |
June 30, 2019 | -6.309M |
March 31, 2019 | -5.821M |
December 31, 2018 | -5.52M |
September 30, 2018 | -5.613M |
June 30, 2018 | -5.669M |
March 31, 2018 | -5.083M |
Date | Value |
---|---|
December 31, 2017 | -4.515M |
September 30, 2017 | -3.876M |
June 30, 2017 | -3.729M |
March 31, 2017 | -4.003M |
December 31, 2016 | -4.426M |
September 30, 2016 | -6.625M |
June 30, 2016 | -10.13M |
March 31, 2016 | -9.142M |
December 31, 2015 | -7.548M |
September 30, 2015 | -4.889M |
June 30, 2015 | -1.680M |
March 31, 2015 | -1.666M |
December 31, 2014 | -3.493M |
September 30, 2014 | -3.898M |
June 30, 2014 | -3.924M |
March 31, 2014 | -4.97M |
December 31, 2013 | -3.855M |
September 30, 2013 | -3.740M |
June 30, 2013 | -2.663M |
March 31, 2013 | -1.874M |
December 31, 2012 | -1.184M |
September 30, 2012 | -1.376M |
June 30, 2012 | -1.618M |
March 31, 2012 | -1.664M |
December 31, 2011 | -1.782M |
Free Cash Flow Range, Past 5 Years
-13.72M
Minimum
Sep 2023
-7.189M
Maximum
Sep 2019
-12.25M
Average
-12.92M
Median
Sep 2020
Free Cash Flow Benchmarks
icad Inc | -5.964M |
Perspective Therapeutics Inc | -23.28M |
Semler Scientific Inc | 25.82M |
Xtant Medical Holdings Inc | -14.80M |
Asensus Surgical Inc | -60.39M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -3.416M |
Cash from Investing (Quarterly) | -0.003M |
Cash from Financing (Quarterly) | -0.1124M |
Free Cash Flow Per Share (Quarterly) | -0.8415 |
Free Cash Flow to Equity (Quarterly) | -3.307M |
Free Cash Flow Yield | -329.4% |